For example, elevated expression of PLSCR1 is implicated in systemic lupus erythematosus and antiphospholipid syndrome [13,14], and increasing PLSCR1 mRNA expression is also suggested to increase the survival rate in acute promyelocytic leukemia and acute myelogenous leukemia patients [15,16]. This evidence concerns the gene PLSCR1 and systemic lupus erythematosus.